Controlled release of vanadium from titanium oxide coatings for improved integration of soft tissue implants

Journal of Biomedical Materials Research - Part A

Volumn 90, Issue 1, 2009, Pages 272-281

  Jarrell, John D ^a   Dolly, Brandon ^a   Morgan, Jeffrey R ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Bioactivity; Fibroblast; Metal ion release; Sol gel techniques; Titanium oxide

Indexed keywords

BIOACTIVE AGENTS; BIOMATERIAL COATINGS; BIORESPONSES; CONTROLLED RELEASE; ELUTION PROFILES; IN-CELL; METAL ION RELEASE; METAL ORGANIC PRECURSORS; MICRON SCALE; MICROPLATES; NANOSCALE-DISPERSION; SOFT TISSUE; SOL-GEL TECHNIQUES; TITANIA COATINGS; TITANIUM OXIDE COATINGS; VANADIUM LOADING; VANADIUM OXIDES; WOUND HEALING; WOUND HEALING DYNAMICS;

BIOLOGICAL MATERIALS; BIOMATERIALS; CELL CULTURE; CELL PROLIFERATION; FIBROBLASTS; GELATION; GELS; METAL IONS; MODULATION; MORPHOLOGY; PATHOLOGY; PROTECTIVE COATINGS; SCANNING ELECTRON MICROSCOPY; SOL-GEL PROCESS; SOL-GELS; SOLS; TITANIUM; TITANIUM DIOXIDE; VANADIUM; VANADIUM ALLOYS; VANADIUM COMPOUNDS;

TITANIUM OXIDES;

BIOMATERIAL; TITANIUM DIOXIDE; VANADIUM;

ARTICLE; CELL ADHESION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; ELUTION; ENERGY DISPERSIVE SPECTROSCOPY; HUMAN; HUMAN CELL; IMPLANT; INFLAMMATION; MATERIAL COATING; MATHEMATICAL MODEL; NEWBORN; SCANNING ELECTRON MICROSCOPY; WOUND HEALING;

CELL ADHESION; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; FIBROBLASTS; GELS; HUMANS; MATERIALS TESTING; MODELS, THEORETICAL; PROSTHESES AND IMPLANTS; SURFACE PROPERTIES; TITANIUM; VANADIUM;

EID: 66849087534     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32093     Document Type: Article

References (36)

1. Kasemo B, Gold J. Implant surfaces and interface processes. Adv Dent Res 1999;13:8-20.
2. Guo Z, Sadler PJ. Reviews: Metals in medicine. Angew Chem Int Ed 1999;38:1512-1531.
3. Branemark R, Branemark P-I, Rydevik B, Myers R. Osseointegration in skeletal reconstruction and rehabilitation: A review. JRRD 2001;3:175-181.
4. Jacobs JJ, Cilbert JL, Urban RM. Current concepts review. Corrosion of metal orthopaedic implants. J Bone Joint Surg Am 1998;80:1554.
5. Overgaard L, Danielsen N, Bjursten LM. Anti-inflammatory properties of titanium in the joint environment. An experimental study in rats. J Bone Joint Surg Br B 1998;80:888-893.
6. Kasemo B, Lausmaa J. Material-tissue interfaces: The role of surface properties and processes. Environ Health Perspect 1994;102(Suppl 5):41-55.
7. Bjursten LM. The bone-implant interface in osseointegration. In: Rydevik B, Branemark PI, Skalak R, editors. International Workshop on Osseointegration in Skeletal Reconstruction and Joint Replacement. Goeborg, Sweden: The Institute for Applied Biotechnology; 1991. p 25-31.
8. Puleo DA, Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 1999;20:2311-2321.
9. Brunski JB, Puleo DA, Nanci A. Biomaterials and biomechanics of oral and maxillofacial implants: Current status and future developments. Int J Oral Maxillofac Implants 2000;15:15-46.
10. Sundgren JE, Bodo P, Lundstrom I. Auger electron spectroscopic studies of the interface between human tissue and implants of titanium and stainless steel. J. Colloid Interface Sci 1986;110:9-20.
11. Effah EA, Bianco PD, Ducheyne P. Crystal structure of the surface oxide layer on titanium and its changes arising from immersion. J Biomed Mater Res 1995;29:73-80.
12. Healy KE, Ducheyne P. Hydration and preferential molecular adsorption on titanium in vitro. Biomaterials 1992;13:553-561.
13. Li P, Ducheyne P. Quasi-biological apatite film induced by titanium in simulated body fluid. J Biomed Mater Res 1998;41: 341-348.
14. Suzuki R, Muyco J, McKittrick J, Frangos JA. Reactive oxygen species inhibited by titanium oxide coatings. J Biomed Mater Res 2003;66:396-402.
15. Suzuki R, Frangos JA. Inhibition of inflammatory species by titanium surfaces. Clin Orthop Relat Res 2000;372:280-289.
16. Kraft CN, Hansis M, Aren S, Menger MD, Vollmar B. Striated muscle microvascular response to silver implants: A comparative in vivo study with titanium and stainless steel. J Biomed Mater Res 2000;49:192-199.
17. Garcia-Vicente S, Yraola F, Marti L, Gonzalez-Munoz E, Garcia-Barrado MJ, Canto C, Abella A, Bour S, Artuch R, Sierra C, Brandi N, Carpene C, Moratinaos J, Camps M, Palacin M, Testar X, Guma A, Albericio F, Royo M, Mian A, Zorzano A. Oral insulin-mimetic compounds that act independently of insulin. Diabetes 2007;56:486-493.
18. Shechter Y. Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes. Diabetes 1999;39:1-5.
19. Srivastava AK. Anti-diabetic and toxic effects of vanadium compounds. Mol Cell Biochem 2000;206:177-182.
20. Yamamoto A, Honma R, Sumita M. Cytotoxicity evaluation of 43 metal salts using murine fibroblasts and osteoblastic cells. J Biomed Mater Res 1998;39:331-340.
21. Huang C, Zhang Z, Ding M, Li J, Ye J, Leonard SS, Shen HM, Butterworth L, Lu Y, Coasta M, Rojanasakul Y, Castranova V, Vallyathan V, Shi X. Vanadate Induces p53 transactivation through hydrogen peroxide and causes apoptosis. J Biol Chem 2000;275:32516-32522.
22. Cortizo AM, Salice VC, Vescina CM, Etcheverry SB. Proliferative and morphological changes induced by vanadium compounds on Swiss 3T3 fibroblasts. BioMetals 1997;10:127-133.
23. Jarrell JD, Eun TH, Samale M, Briant C, Sheldon B, Morgan JR. Use of specialized metal oxide films for delivery of bioactive metal compounds. Orthopaedic Res Soc 2007;32:1590.
24. Ehrlich HP, Keefer KA, Maish GO, Myers RL, Mackay DR. Vanadate ingestion increases the gain in wound breaking strength and leads to better organized collagen fibers in rats during healing. Plast Reconstr Surg 2001;107:471-477.
25. Ehrlich HP, Keefer KA, Myers RL, Passaniti A. Vanadate and the absence of myofibroblasts in wound contraction. Arch Surg 1999;134:494-501.
26. Moyer KE, Saba AA, Hauck RM, Ehrlich HP. Systemic vanadate ingestion modulates rat tendon repair. Exp Mol Pathol 2003;75:80-88.
27. Chen J, Iosifidis M, Zhu J, Tatarintsev I, Wang JH. Vanadate ingestion enhances the organization and collagen fibril diameter of rat healing medical collateral ligaments. Knee Surg Sports Traumatol Arthrose 2006;14:750-755.
28. Mackay DJ, Moyer KE, Saggers GC, Myers RL, Mackay DR, Ehrlich HP. Topical vanadate optimizes collagen organization within granulation tissue. Wound Repair Regen 2003;11:204-212.
29. Takada Y, Hashimoto M, Kasahara J, Aihara K, Fukunaga K. Cytoprotective effect of sodium orthovanadate on ischemia/reperfusion-induced injury in the rat heart involves Akt activation and inhibition of fodrin breakdown and apoptosis. J Pharmacol Exp Ther 2004;311:1249-1255.
30. Jarrell JD, Eun TH, Samale M, Briant C, Sheldon B, Morgan JR. Metal oxide coated cell culture arrays for rapid biological screening. J Biomed Mater Res A 2007;83:853-860.
31. Garcia AJ. A centrifuge cell adhesion assay for high-through-put screening of biomaterial surfaces. J Biomed Mater Res A 2003;67:328-333.
32. Garcia AJ, Gallant ND. Stick and grip: Measurement systems and quantitative analyses of integrin-mediated cell adhesion strength. Cell Biochem Biophys 2003;39:61-73.
33. Ziegler G, Gollwitzer H, Heidenau F, Mittelmeir W, Stenzel F. Anti-infectious, biocompatible titanium coating for implants, and method for the production thereof. U.S. Pat. 0,161,256 (2006).
34. Thompson KH, Orvig C. Vanadium in diabetes: 100 years from phase 0 to phase I. J Inorg Biochem 2006;100:1925-1935.
35. Brand RM, Duensing G, Hamel FG. Iontophoretic delivery of an insulin-mimetic peroxovanadium compound. Int J Pharm 1997;146:115-122.
36. Brand RM, Hannah TL. A combination of iontophoresis and the chelating agent 1, 10 phenanthroline act synergistically as penetration enhancers. AAPS Pharmsci 2000;2:E35.